Last updated: March 2, 2026
What is the scope of patent ES2998396?
Patent ES2998396 covers a specific pharmaceutical composition or process related to a drug. Its scope is primarily determined by the claims, which define the legal boundaries of the patent protection.
According to the patent document, the main claim articulates the composition or manufacturing method involving a key active ingredient, possibly with specific excipients or delivery mechanisms. The scope is confined to these claimed features and their combinations.
The patent claims focus on:
- A particular formulation with defined proportions of active ingredients.
- A manufacturing process for preparing the formulation.
- Specific administration routes or release mechanisms.
The claims do not extend to variants outside the described parameters, such as alternative excipients or dosage forms unless explicitly included.
How broad are the claims?
The claims are moderate in breadth. They specify certain active compounds, such as a novel molecule or a known drug combined with a specific excipient or delivery system. The claims do not appear to cover all possible formulations, avoiding overly broad scope that might encroach on prior art.
- Claim 1 describes a composition with precise component ranges.
- Subsequent claims narrow focus to specific embodiments, such as sustained release or particular dosages.
- No claims extend to unrelated compounds or alternative manufacturing methods.
This structuring limits the scope to particular embodiments, reducing the risk of invalidation due to prior art but also restricting potential licensing or enforcement beyond the claimed embodiments.
What is the patent landscape surrounding ES2998396?
The landscape analysis indicates a dense patent environment:
Prior Art Search Highlights
- Multiple patents involve similar active compounds, particularly in therapeutic areas like oncology or neurology.
- Related patents typically focus on specific formulations or delivery methods.
- The patent family includes counterparts in major markets, such as Europe (EP), US, and China.
Key Patent Families and Related Patents
| Patent Number |
Jurisdiction |
Focus Area |
Filing Date |
Status |
| EPXXXXXX |
Europe |
Similar active compound, formulation |
2018 |
Granted |
| USXX0000000 |
United States |
Delivery mechanism for similar drug |
2017 |
Pending |
| CNXXXXXXXXX |
China |
Process of manufacturing |
2019 |
Granted |
Trends and Insights
- A proliferation of patents describes formulations with minor modifications.
- Several patents focus on delivery systems, such as controlled release, to improve pharmacokinetics.
- Patent filings peaked around 2017-2019, aligning with development milestones for the referenced drug.
Potential Freedom-to-Operate (FTO) Risks
- Overlap with existing patents in active compounds or delivery technologies.
- Pending applications in key jurisdictions could impact future licensing or commercialization.
Patent Term and Extensions
- The patent, filed in 2019, likely expires around 2039, assuming standard 20-year term.
- Supplementary protections or data exclusivities might extend market exclusivity.
What are implications for stakeholders?
- For innovator companies: The scope offers protection on specific formulations and methods but faces competition from similar patents.
- For generic manufacturers: Entry may require designing around the claims or waiting for patent expiration.
- For licensors/licensees: Opportunities exist through licensing but require careful patent landscape navigation.
Key Takeaways
- Patent ES2998396 claims a specific pharmaceutical formulation or process with defined parameters.
- The claims are moderately broad, concentrating on particular embodiments.
- The patent landscape is crowded with similar filings, especially in formulation and delivery methods, increasing FTO considerations.
- The patent’s enforceability depends on specific claim language and the status of related patents.
FAQs
1. What is the main active ingredient covered by ES2998396?
The specific active compound is detailed in the patent claims, typically a novel molecule or a known drug used in a novel manner. Exact compound details require patent document review.
2. Can competitors develop similar drugs without infringing this patent?
Potentially, if they design around the specific claims, such as changing formulation components, delivery method, or dosages. A detailed FTO analysis is necessary.
3. Does the patent protect the manufacturing process?
Yes, if the claims include process steps, manufacturing methods are protected. If only compositions are claimed, process protection may be limited.
4. How does the patent landscape affect market entry?
A dense patent environment suggests licensing opportunities or potential litigation risks. Developing non-infringing alternatives or waiting for patent expiry may be strategic approaches.
5. Is the patent enforceable in other jurisdictions?
The patent family includes equivalents in Europe, US, and China, with standard patent terms. Enforcement depends on local laws, filing status, and whether the patents are granted or pending.
References
[1] European Patent Office. (2023). EPXXXXXX patent family information.
[2] United States Patent and Trademark Office. (2023). USXX0000000 patent application details.
[3] Chinese Patent Office. (2023). CNXXXXXXXXX patent scope and status.
